116 related articles for article (PubMed ID: 12500856)
21. The value of gallium imaging after therapy for Hodgkin's disease.
Bogart JA; Chung CT; Mariados NF; Vermont AI; Lemke SM; Grethlein S; Graziano SL
Cancer; 1998 Feb; 82(4):754-9. PubMed ID: 9477109
[TBL] [Abstract][Full Text] [Related]
22. Tc-99m sestamibi imaging in the diagnostic assessment of patients with lymphomas: comparison with clinical and radiological evaluation.
Maurea S; Acampa W; Varrella P; De Rosa V; Fimiani P; Abate G; Salvatore M
Clin Nucl Med; 1998 May; 23(5):283-90. PubMed ID: 9596152
[TBL] [Abstract][Full Text] [Related]
23. Pretherapy Gallium-67 scanning in paediatric patients with Hodgkin's disease.
Shah Syed GM; Younis MN; Usmani GN; Zafar N
Med Princ Pract; 2004; 13(2):74-7. PubMed ID: 14755138
[TBL] [Abstract][Full Text] [Related]
24. Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.
Salloum E; Brandt DS; Caride VJ; Cornelius E; Zelterman D; Schubert W; Mannino T; Cooper DL
J Clin Oncol; 1997 Feb; 15(2):518-27. PubMed ID: 9053473
[TBL] [Abstract][Full Text] [Related]
25. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.
Ionescu I; Brice P; Simon D; Guermazi A; Leblanc T; Rousselot P; Gossot D; Meignin V; Gisselbrecht C; Rain JD
Med Oncol; 2000 May; 17(2):127-34. PubMed ID: 10871819
[TBL] [Abstract][Full Text] [Related]
26. A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease.
Karimjee S; Brada M; Husband J; McCready VR
Eur J Cancer; 1992; 28A(11):1856-7. PubMed ID: 1389526
[TBL] [Abstract][Full Text] [Related]
27. Use of Tl-201 to detect untreated pediatric Hodgkin disease.
Fletcher BD; Kauffman WM; Kaste SC; Winer-Muram HT; Fang L; Chen G; Hudson M
Radiology; 1995 Sep; 196(3):851-5. PubMed ID: 7644655
[TBL] [Abstract][Full Text] [Related]
28. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
Wirth A; Seymour JF; Hicks RJ; Ware R; Fisher R; Prince M; MacManus MP; Ryan G; Januszewicz H; Wolf M
Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
[TBL] [Abstract][Full Text] [Related]
29. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.
Harris EW; Rakow JI; Weiner M; Agress H
J Nucl Med; 1993 Aug; 34(8):1326-30. PubMed ID: 8326393
[TBL] [Abstract][Full Text] [Related]
30. Gallium-67 citrate scanning in Hodgkin's disease and non-Hodgkin's lymphoma.
Horn NL; Ray GR; Kriss JP
Cancer; 1976 Jan; 37(1):250-7. PubMed ID: 1247959
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Tl-201 chloride and Ga-67 citrate scintigraphy in the diagnosis of thyroid tumor: concise communication.
Senga O; Miyakawa M; Shirota H; Makiuchi M; Yano K; Miyazawa M; Takizawa M
J Nucl Med; 1982 Mar; 23(3):225-8. PubMed ID: 6950032
[TBL] [Abstract][Full Text] [Related]
32. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas.
Ziegels P; Nocaudie M; Huglo D; Deveaux M; Detourmignies L; Wattel E; Marchandise X
Eur J Nucl Med; 1995 Feb; 22(2):126-31. PubMed ID: 7758499
[TBL] [Abstract][Full Text] [Related]
33. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
Nikpoor N; Aliabadi P; Diaz L; Mannting F
Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
[TBL] [Abstract][Full Text] [Related]
35. Ga-67 imaging in Hodgkin's disease.
Huys J; Schelstraete K; Simons M
Clin Nucl Med; 1982 Apr; 7(4):174-9. PubMed ID: 7075081
[TBL] [Abstract][Full Text] [Related]
36. A comparative study between planar Ga-67, Tl-201 images, chest x-ray, and x-ray CT in inoperable non-small cell carcinoma of the lung.
Ragheb AM; Elgazzar AH; Ibrahim AK; Higazi E; Mahmoud AR; el-Saleh K; Omar YT; Abdel-Dayem HM
Clin Nucl Med; 1995 May; 20(5):426-33. PubMed ID: 7628147
[TBL] [Abstract][Full Text] [Related]
37. Tl-201 scintigraphy, mammography and ultrasonography in the evaluation of palpable and nonpalpable breast lesions: a correlative study.
Ozdemir A; Oznur II; Vural G; Atasever T; Karabacak NI; Gökçora N; Işik S; Unlü M
Eur J Radiol; 1997 Feb; 24(2):145-54. PubMed ID: 9097057
[TBL] [Abstract][Full Text] [Related]
38. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Guay C; Lépine M; Verreault J; Bénard F
J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Tc-99m pertechnetate with Tl-201 and Ga-67 scintigraphy of malignant soft-tissue tumors.
Abe H; Terui S; Terauchi T; Muramatsu Y; Yokayama R; Ohtomo K; Beppu Y; Fukuma H
Clin Nucl Med; 1997 Jan; 22(1):38-41. PubMed ID: 8993872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
